Clinical Trial Update: Validation of DNA Methylation Markers for Universal and Site-specific Guided Cancer Detection, VANGUARD Study

View source ↗

Summary

A Mayo Clinic-led clinical trial validating DNA methylation markers for universal and site-specific cancer detection (NCT06304168) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Cancer
• Solid Malignant Neoplasm

Snippet

Sponsor: Mayo Clinic | Conditions: Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm | Status: RECRUITING